Cargando…
JianPi HuaZhuo XingNao formula (Chinese herbal medicine) for the treatment of minimal hepatic encephalopathy: a protocol for a randomized, placebo-controlled pilot trial
BACKGROUND: Minimal hepatic encephalopathy (MHE) is a subclinical state of hepatic encephalopathy with the possibility of developing into overt hepatic encephalopathy (OHE) and having adverse outcomes. However, no preventative medicine for MHE has been recommended so far. The aim is to evaluate the...
Autores principales: | Li, XiaoKe, Gan, DaNan, Li, Ying, Zhang, Peng, Li, ZhiGuo, Du, HongBo, Zhang, LuDan, Cheng, Yuan, Zhang, YaQiang, Liang, YiJun, Ye, YongAn |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5944523/ https://www.ncbi.nlm.nih.gov/pubmed/29703024 http://dx.doi.org/10.1097/MD.0000000000010526 |
Ejemplares similares
-
Explore the active ingredients and potential mechanisms of JianPi QingRe HuaYu Methods in the treatment of gastric inflammation-cancer transformation by network pharmacology and experimental validation
por: Nie, Kechao, et al.
Publicado: (2023) -
XingNaoJing injection ameliorates cerebral ischaemia/reperfusion injury via SIRT1-mediated inflammatory response inhibition
por: Zhang, Yue-Ming, et al.
Publicado: (2019) -
16S rRNA sequencing-based evaluation of the protective effects of Hua-Zhuo-Jie-Du on rats with chronic atrophic gastritis
por: Zhou, Pingping, et al.
Publicado: (2022) -
XingNaoJing, prescription of traditional Chinese medicine, prevents autophagy in experimental stroke by repressing p53-DRAM pathway
por: Wei, Gang, et al.
Publicado: (2015) -
JianPi-QingHua formula attenuates nonalcoholic fatty liver disease by regulating the AMPK/SIRT1/NF-κB pathway in high-fat-diet-fed C57BL/6 mice
por: Tian, Jing, et al.
Publicado: (2023)